Heart End Period Cash Flow from 2010 to 2024

HSCSW Stock  USD 0.03  0.00  0.00%   
Heart Test End Period Cash Flow yearly trend continues to be fairly stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2024. During the period from 2010 to 2024, Heart Test End Period Cash Flow regression line of quarterly data had mean square error of 2.1 T and geometric mean of  800,951. View All Fundamentals
 
End Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
5.8 M
Current Value
6.1 M
Quarterly Volatility
1.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 349, Dividend Yield of 0.0 or PTB Ratio of 0.42. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Latest Heart Test's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Heart Test Laboratories over the last few years. It is Heart Test's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Heart End Period Cash Flow Regression Statistics

Arithmetic Mean1,345,094
Geometric Mean800,951
Coefficient Of Variation141.01
Mean Deviation1,270,782
Median496,853
Standard Deviation1,896,764
Sample Variance3.6T
Range5.6M
R-Value0.67
Mean Square Error2.1T
R-Squared0.45
Significance0.01
Slope283,059
Total Sum of Squares50.4T

Heart End Period Cash Flow History

20246.1 M
20235.8 M
20221.7 M
2021918.3 K
2020723.5 K

About Heart Test Financial Statements

Heart Test investors use historical fundamental indicators, such as Heart Test's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heart Test. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow5.8 M6.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.